Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers

Clin Infect Dis. 2012 Jan 1;54(1):88-90. doi: 10.1093/cid/cir755. Epub 2011 Nov 3.

Abstract

In 118 previous hepatitis B surface antigen (HBsAg) carriers, low-level hepatitis B (HBV) viremia persisted at a rate of 15%-20% for >10 years after HBsAg seroclearance. The frequency of HBV viremia was significantly (P = .002) lower in patients with anti-HBsAg seroconversion (6 of 69 [8.7%]) than in those without seroconversion (15 of 49 [30.6%]).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Carrier State / virology*
  • Female
  • Hepatitis B Surface Antigens / blood*
  • Hepatitis B virus / isolation & purification*
  • Hepatitis B, Chronic / virology*
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Viremia / epidemiology*

Substances

  • Hepatitis B Surface Antigens